Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
bOPV vs tOPV vs IPV sequential schedules in infants and children
CTR20140798Phase 3Completed
- Sponsor
- Beijing Tiantan Biological
- Start
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bivalent oral poliovirus vaccine types 1 and 3 (human diploid cell) in poliomyelitis, sponsored by Beijing Tiantan Biological. Started Feb 2015; status: completed.
02
Drugs
bivalent oral poliovirus vaccine types 1 and 3 (human diploid cell)
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20140798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140798.